Board Of Directors
Lena A. Basile, Ph.D., J.D., President and Chief Executive Officer
Dr. Basile founded Neumedicines in 2003 and is the driving force behind its success. Dr. Basile wrote the original IL-12 technology patent applications and secured multiple funded peer-reviewed grants and contracts. To date, Dr. Basile has secured over $70 million in non-dilutive government funding for Neumedicines. Dr. Basile received her doctorate in chemistry from Columbia University in inorganic complex-DNA interactions. She then went on to complete postdoctoral studies at Yale University in the department of Molecular Biology and Biochemistry, where she studied protein-DNA interactions of several DNA-binding proteins including HIV-related proteins. Dr. Basile has over 20 years of scientific experience and also holds a doctorate in law from the University of Houston Law Center. She is a member of the State Bar of California and, prior to founding Neumedicines, practiced as an intellectual property attorney for 7 years.
David Morash, MBA
Mr. Morash is a member of the company’s Board of Directors. He served as Chief Financial Officer of the company from 2013-2015 and brings to Neumedicines more than 30 years of executive-level financial and executive experience. Most recently Mr. Morash was Chief Financial Officer of ISE Corporation, where he was instrumental in several fundraises and in preparing the company for an initial public offering. Prior to ISE, he served as President, Chief Operating Officer and Chief Financial Officer of publicly traded Axesstel, Inc., which he helped to take public. He also served as Executive Vice President and Chief Financial Officer of publicly traded Remec. Earlier in his career, he was Executive Vice President of Wireless Knowledge, a joint venture between Qualcomm and Microsoft, and Executive Vice President and Chief Financial Officer of Safeskin Corporation, a medical device company rated by Forbes as the Best Small Company in the U.S. Mr. Morash serves on the Board of Directors of California Safe Soil, LLC, a privately held San Diego-based company he co-founded. He holds BA and MBA degrees from Columbia University.
© 2009 Neumedicines Inc. All rights reserved.